Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




GEN podcasts

*Podcasts play in a pop-up window. Please make sure your pop-up blocker is off.

GEN’s editor in chief, John Sterling, interviews life science academic and biotech industry leaders on important research, technology, and trends. These podcasts will keep you informed with all the important details you need.

MICROSIZING GENETICS TESTING

11/6/2008

- Interview with James Landers, Ph.D., Professor of Chemistry, Professor of Mechanical Engineering, and Associate Professor of Pathology, University of Virginia

Using new "lab-on-a-chip" technology, researchers at the University of Virginia hope to create a hand-held device that may eventually allow physicians, crime scene investigators, pharmacists, even the general public, to quickly and inexpensively conduct DNA tests from almost anywhere, without need for a complex and expensive central laboratory. The scientists are simplifying and miniaturizing the analytical processes so this work can be done in the field, away from traditional laboratories, with very fast analysis times, and at a greatly reduced cost.


During this week's podcast, Dr. James Landers, a professor of chemistry and mechanical engineering and associate professor of pathology, provides specific details about his group's device. Dr. Landers also discusses the ways this technology has matured over the past few years and he tackles the issue of when we might actually see the first approved lab-on-a-chip device on the market.
James Landers, Ph.D., is Professor of Chemistry, Professor of Mechanical Engineering, and Associate Professor of Pathology at the University of Virginia.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll